Fig. 2From: Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLCWestern blot analysis of Ido-1, PD-L1, MAPK, phospho-MAPK (pMAPK), MEK, phospho-MEK (pMEK), CTLA4, TIM3 and LAG3 on protein lysates from NSCLC cell lines A549, H460 and H1299. α-tubulin was included as a loading control. Control: untreated control, Mek-I: selumetinib, IFNγ: interferon-γBack to article page